SKHY Stock Analysis: SK Hynix American | US
Semiconductors | US, USA | Market Cap: 1.143.015m USD | 12M Return: -12.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.28B
Rev. Trend: 98.3%
Warnings
Tailwinds
Seasonality 0.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SK Hynix Inc. is a South Korea-based global semiconductor manufacturer that produces memory and non-memory chips, including DRAM, NAND flash memory, SSDs, and MCP products, while also operating a foundry business. The company sells its components to server, networking, mobile, PC, consumer, and automotive customers across Korea, China, the rest of Asia, the United States, and Europe. Founded in 1949 and headquartered in Icheon-si, South Korea, SK Hynix was formerly known as Hynix Semiconductor Inc. before adopting its current name in March 2012.
The company is one of the worlds leading memory chip producers and is generally grouped with Samsung Electronics and Micron Technology as the dominant suppliers of DRAM globally. Its product mix spans commodity-style memory components, which are highly cyclical and tied to data center, mobile, and PC demand, alongside its emerging foundry segment, which fabricates logic chips for third-party designers.
Trading on the US market under the ticker SKHY as a Mega Cap stock, SK Hynix represents the Technology sector, specifically the Semiconductors industry, and is structured as a common stock listing of its American Depositary Shares.
- HBM3E demand from AI accelerators lifts memory revenue
- DRAM and NAND ASP recovery expands segment margins
- US export curbs on China memory chips pressure regional sales
| Net Income: 161965b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 14.78 > 1.0 |
| NWC/Revenue: 50.69% < 20% (prev 25.75%; Δ 24.95% < -1%) |
| CFO/TA 0.36 > 3% & CFO 126926b > Net Income 161965b |
| Net Debt (-63420b) to EBITDA (160106b): -0.40 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.13b) vs 12m ago 0.21% < -2% |
| Gross Margin: 76.27% > 18% (prev 53.91%; Δ 22.36% > 0.5%) |
| Asset Turnover: 79.16% > 50% (prev 59.81%; Δ 19.35% > 0%) |
| Interest Coverage Ratio: 188.5 > 6 (EBIT TTM 145216b / Interest Expense TTM 770b) |
| A: 0.27 (Total Current Assets 156156b - Total Current Liabilities 60257b) / Total Assets 348862b |
| B: 0.69 (Retained Earnings 242270b / Total Assets 348862b) |
| C: 0.61 (EBIT TTM 145216b / Avg Total Assets 238975b) |
| D: 3.05 (Book Value of Equity 262693b / Total Liabilities 86169b) |
| Altman-Z'' = 11.35 = AAA |
| DSRI: 1.42 (Receivables 49118b/14137b, Revenue 189171b/77211b) |
| GMI: 0.71 (GM 53.91% / 76.27%) |
| AQI: 2.25 (AQ_t 0.30 / AQ_t-1 0.13) |
| SGI: 2.45 (Revenue 189171b / 77211b) |
| TATA: 0.10 (NI 161965b - CFO 126926b) / TA 348862b) |
| Beneish M = -1.15 (Cap -4..+1) = D |
As of November 03, 2026, the stock is trading at USD 147.71 with a total of 21,343,835 shares traded. Over the past week, the price has changed by +3.57%, over one month by -24.30%, over three months by +3.52% and over the past year by -12.07%.
Current recommended Stop Loss: 127.00 (which is 14% or 2.2 ATR below the current price).
SK Hynix American has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy SKHY.
- StrongBuy: 9
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 260.6 | 76.5% |
Market Cap KRW = 1535184b (1143b USD * 1343.1 USD.KRW)
P/E Trailing = 10.3374
P/E Forward = 4.5662
P/S = 0.006
P/B = 5.8655
P/EG = 0.2342
Revenue TTM = 189171b KRW
EBIT TTM = 145216b KRW
EBITDA TTM = 160106b KRW
Long Term Debt = 12728b KRW (from longTermDebt, last quarter)
Short Term Debt = 6384b KRW (from shortTermDebt, last quarter)
Debt = 23640b KRW (from shortLongTermDebtTotal, last quarter) + Leases 2527b
Net Debt = -63420b KRW (calculated: Debt 23640b - CCE 87060b)
Enterprise Value = 1471764b KRW (1535184b + Debt 23640b - CCE 87060b)
Interest Coverage Ratio = 188.5 (Ebit TTM 145216b / Interest Expense TTM 770b)
EV/FCF = 16.14x (Enterprise Value 1471764b / FCF TTM 91184b)
FCF Yield = 6.20% (FCF TTM 91184b / Enterprise Value 1471764b)
FCF Margin = 48.20% (FCF TTM 91184b / Revenue TTM 189171b)
Net Margin = 85.62% (Net Income TTM 161965b / Revenue TTM 189171b)
Gross Margin = 76.27% ((Revenue TTM 189171b - Cost of Revenue TTM 44894b) / Revenue TTM)
Gross Margin QoQ = 83.20% (prev 79.27%)
Tobins Q-Ratio = 4.22 (Enterprise Value 1471764b / Total Assets 348862b)
Interest Expense / Debt = 3.26% (Interest Expense 770b / Debt 23640b)
Taxrate = 21.60% (44657b / 206769b)
NOPAT = 113853b (EBIT 145216b * (1 - 21.60%))
Current Ratio = 2.59 (Total Current Assets 156156b / Total Current Liabilities 60257b)
Debt / Equity = 0.09 (Debt 23640b / totalStockholderEquity, last quarter 262693b)
Debt / EBITDA = -0.40 (Net Debt -63420b / EBITDA 160106b)
Debt / FCF = -0.70 (Net Debt -63420b / FCF TTM 91184b)
Total Stockholder Equity = 161871b (last 4 quarters mean from totalStockholderEquity)
RoA = 67.78% (Net Income 161965b / Total Assets 348862b)
RoE = 100.1% (Net Income TTM 161965b / Total Stockholder Equity 161871b)
RoCE = 83.17% (EBIT 145216b / Capital Employed (Equity 161871b + L.T.Debt 12728b))
RoIC = 39.87% (NOPAT 113853b / Invested Capital 285531b)
WACC = 19.07% (E(1535184b)/V(1558824b) * Re(19.32%) + D(23640b)/V(1558824b) * Rd(3.26%) * (1-Tc(0.22)))
Discount Rate = 19.32% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 53.38 | Cagr: 1.57%
[DCF] Terminal Value 50.72% ; FCFF base≈60572b ; Y1≈69436b ; Y5≈102192b
[DCF] Fair Price = 82.9k (EV 520951b - Net Debt -63420b = Equity 584371b / Shares 7.05b; r=19.07% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 98.28 | Revenue CAGR: 82.32% | SUE: N/A | # QB: 0
EPS current Quarter (2027-03-31): EPS=8.70 | Chg30d=+21.95% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=26.89 | Chg30d=+1.09% | Revisions=+17% | GrowthEPS=+0.0% | GrowthRev=+274.2%
EPS next Year (2027-12-31): EPS=42.40 | Chg30d=+24.76% | Revisions=-17% | GrowthEPS=+57.7% | GrowthRev=+58.5%
[Analyst] Revisions Ratio: -10% (up=3, down=4)